Publication | Open Access
FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
28
Citations
0
References
2021
Year
No additional data available for this publication yet. Check back later!